×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
9494 views

Modérateur : Pr Jean-Marc Classe

 

18:00
Qu’est-ce que la réponse pathologique complète et quels sous types sont concernés ?
Dr Anne Vincent-Salomon
 
18:15
A qui proposer de la CNA alors que la chirurgie première est faisable et quelles sont les perspectives ?
Dr Mahasti Saghatchian
 
18:30
A qui proposer une chimiothérapie néoadjuvante alors que l’intervention première est faisable et existe-t-il des perspectives de désescalade chirurgicale ?
Dr Marie Bannier
 
18:45
Quel impact sur la chirurgie axillaire ?
Pr Jean-Marc Classe
 
19:00 Débat/discussion - Réponses aux questions

 

Shooting date : 2021-12-21
Last update : 2022-03-09
1 comment
Join the Discussion
  • Bradley Sarnick Farel M. Merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Tuesday, October 15th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, October 15th 2024 from 06am to 07:30am (GMT-10)
    San Francisco : Tuesday, October 15th 2024 from 09am to 10:30am (GMT-7)
    New York : Tuesday, October 15th 2024 from 12pm to 01:30pm (GMT-4)
    Buenos Aires : Tuesday, October 15th 2024 from 01pm to 02:30pm (GMT-3)
    Reykjavik : Tuesday, October 15th 2024 from 04pm to 05:30pm (GMT)
    London / Dublin : Tuesday, October 15th 2024 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Tuesday, October 15th 2024 from 06pm to 07:30pm (GMT+2)
    Istanbul : Tuesday, October 15th 2024 from 07pm to 08:30pm (GMT+3)
    Moscou / Dubaï : Tuesday, October 15th 2024 from 08pm to 09:30pm (GMT+4)
    Bangkok : Tuesday, October 15th 2024 from 11pm to 12:30am (GMT+7)
    Shanghai : Wednesday, October 16th 2024 from 12am to 01:30am (GMT+8)
    Tokyo : Wednesday, October 16th 2024 from 01am to 02:30am (GMT+9)
    Sydney : Wednesday, October 16th 2024 from 03am to 04:30am (GMT+11)
    Wellington : Wednesday, October 16th 2024 from 05am to 06:30am (GMT+13)

    Nouveautés dans la détection du ganglion sentinelle du cancer du sein

    Thursday, December 2nd 2021 from 06pm to 07pm (GMT+2)
    Honolulu : Thursday, December 2nd 2021 from 06am to 07am (GMT-10)
    San Francisco : Thursday, December 2nd 2021 from 08am to 09am (GMT-8)
    New York : Thursday, December 2nd 2021 from 11am to 12pm (GMT-5)
    Buenos Aires : Thursday, December 2nd 2021 from 01pm to 02pm (GMT-3)
    London / Dublin : Thursday, December 2nd 2021 from 04pm to 05pm (GMT)
    Paris / Berlin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
    Istanbul : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+2)
    Moscou / Dubaï : Thursday, December 2nd 2021 from 08pm to 09pm (GMT+4)
    Bangkok : Thursday, December 2nd 2021 from 11pm to 12am (GMT+7)
    Shanghai : Friday, December 3rd 2021 from 12am to 01am (GMT+8)
    Tokyo : Friday, December 3rd 2021 from 01am to 02am (GMT+9)
    Sydney : Friday, December 3rd 2021 from 02am to 03am (GMT+10)
    Wellington : Friday, December 3rd 2021 from 04am to 05am (GMT+12)

    SLNB or TAD after NAC in cN1 / ycN0 patients

    Share
    Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
    Honolulu : Wednesday, May 10th 2023 from 06am to 07:30am (GMT-10)
    San Francisco : Wednesday, May 10th 2023 from 09am to 10:30am (GMT-7)
    New York : Wednesday, May 10th 2023 from 12pm to 01:30pm (GMT-4)
    Buenos Aires : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT-3)
    Reykjavik : Wednesday, May 10th 2023 from 04pm to 05:30pm (GMT)
    London / Dublin : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+1)
    Paris / Berlin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
    Istanbul : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+3)
    Moscou / Dubaï : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+4)
    Bangkok : Wednesday, May 10th 2023 from 11pm to 12:30am (GMT+7)
    Shanghai : Thursday, May 11th 2023 from 12am to 01:30am (GMT+8)
    Tokyo : Thursday, May 11th 2023 from 01am to 02:30am (GMT+9)
    Sydney : Thursday, May 11th 2023 from 03am to 04:30am (GMT+11)
    Wellington : Thursday, May 11th 2023 from 05am to 06:30am (GMT+13)

    Cancer du sein : actualités et essais en cours, vers où allons-nous ?

    Share
    Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+2)
    Honolulu : Tuesday, March 19th 2024 from 06am to 07:30am (GMT-10)
    San Francisco : Tuesday, March 19th 2024 from 08am to 09:30am (GMT-8)
    New York : Tuesday, March 19th 2024 from 11am to 12:30pm (GMT-5)
    Buenos Aires : Tuesday, March 19th 2024 from 01pm to 02:30pm (GMT-3)
    London / Dublin : Tuesday, March 19th 2024 from 04pm to 05:30pm (GMT)
    Paris / Berlin : Tuesday, March 19th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, March 19th 2024 from 06pm to 07:30pm (GMT+2)
    Moscou / Dubaï : Tuesday, March 19th 2024 from 08pm to 09:30pm (GMT+4)
    Bangkok : Tuesday, March 19th 2024 from 11pm to 12:30am (GMT+7)
    Shanghai : Wednesday, March 20th 2024 from 12am to 01:30am (GMT+8)
    Tokyo : Wednesday, March 20th 2024 from 01am to 02:30am (GMT+9)
    Sydney : Wednesday, March 20th 2024 from 02am to 03:30am (GMT+10)
    Wellington : Wednesday, March 20th 2024 from 04am to 05:30am (GMT+12)

    Prise en charge actuelle pour les cancers du sein triples négatifs métastatiques

    Les webinars du réseau FEM-NET

    Share
    Scroll Up